Clinical trial
Effect of Sildenafil on the Microcirculatory Blood Flow and on the Endothelial Progenitor Cells in Patients With Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
NCT01347008 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Sildenafil on the Microcirculatory Blood Flow and on the Endothelial Progenitor Cells in Patients With Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
- Lead sponsor
- Federal University of São Paulo
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- January 31, 2013
- Enrollment
- 41 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
raynaud phenomenon, scleroderma, diffuse, scleroderma, limited, scleroderma, systemic